Business Update
Theratechnologies selects Comintell's KXC competitive intelligence software
Published in AIDS Weekly, October 9th, 2006
Being a late-stage biotech company, the need for strategic intelligence is fundamental for Theratechnologies and, according to Comintell, they now have a tool that helps them identify growth opportunities and gives early warning of competitive threats.
"Theratechnologies has a clear vision of what they want to accomplish with their strategic intelligence work," said Jesper Martell, CEO of Comintell. "In...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-10-09)
More Articles from AIDS Weekly
- HIV/AIDS Epidemiology
HIV drug-resistant and nonsubtype B strains increasingly common in perinatally infected - HIV/AIDS Pathogenesis
Protection against X4-tropic HIV-1 superinfection involves CD4 HIV-1 Nef mechanisms - HIV/AIDS Prognostics
Time from HIV-1 seroconversion to CD4/CD8 ratio inversion predicts time to AIDS - HIV/AIDS Therapy
Interleukin-2 reconstitutes defective HIV- and CMV-specific CD8+ cell proliferation in HIV/AIDS - HIV/AIDS Transmission
Breastfeeding plus zidovudine reduces mortality rate at 7 months compared with formula feeding - Antifungals
Combination antifungal therapy valuable in pre-emptive management of high-risk patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
